CurveBeam AI Limited

Equities

CVB

AU0000289761

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. 11:11:02 16/07/2024 am IST 5-day change 1st Jan Change
0.235 AUD +6.82% Intraday chart for CurveBeam AI Limited +2.17% -43.37%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
CurveBeam AI Secures US FDA Clearance for CT Scanner; Shares Up 6% MT
CurveBeam AI's Purchase Orders Up in Fiscal Q4 on US Demand MT
84,049 Ordinary Shares of CurveBeam AI Limited are subject to a Lock-Up Agreement Ending on 5-JUN-2024. CI
CurveBeam AI Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI
9,669,464 Ordinary Shares of CurveBeam AI Limited are subject to a Lock-Up Agreement Ending on 23-FEB-2024. CI
3,544,391 Ordinary Shares of CurveBeam AI Limited are subject to a Lock-Up Agreement Ending on 21-FEB-2024. CI
5,371,923 Options of CurveBeam AI Limited are subject to a Lock-Up Agreement Ending on 18-FEB-2024. CI
2,619,821 Ordinary Shares of CurveBeam AI Limited are subject to a Lock-Up Agreement Ending on 13-FEB-2024. CI
1,455,452 Options of CurveBeam AI Limited are subject to a Lock-Up Agreement Ending on 7-FEB-2024. CI
11,447,794 Ordinary Shares of CurveBeam AI Limited are subject to a Lock-Up Agreement Ending on 10-NOV-2023. CI
4,685,495 Options of CurveBeam AI Limited are subject to a Lock-Up Agreement Ending on 31-OCT-2023. CI
8,433,924 Ordinary Shares of CurveBeam AI Limited are subject to a Lock-Up Agreement Ending on 31-OCT-2023. CI
CurveBeam AI Limited Reports Earnings Results for the Full Year Ended June 30, 2023 CI
CurveBeam AI Limited Appoints of Arun Bahadur Singh as Director CI
CurveBeam AI Limited has completed an IPO in the amount of AUD 25 million. CI
CurveBeam AI Limited has filed an IPO in the amount of AUD 25 million. CI
Chart CurveBeam AI Limited
More charts
Curvebeam AI Ltd is engaged in the research, design, and manufacturing of cone beam computed tomography (CT) imaging systems for the orthopedic specialties. The Company is engaged in providing point-of-care diagnostic cone beam CT imaging solutions with artificial intelligence (AI) and deep learning AI (DLAI). Its product categories include orthopedics and bone health. Its orthopedics products include HiRise, LineUP, pedCAT Premium, pedCAT, InReach, and CubeVue Software. Its bone health products include InReach HR-pQCT, and OSSView. HiRise is a bilateral, weight bearing CT imaging of the entire lower extremities including hips/pelvis, distal upper extremities. LineUP is a bilateral, weight bearing CT imaging of the distal lower extremities and distal upper extremities. InReach HR-pQCT is a high resolution peripheral quantitative CT (HR-pQCT) imaging system designed for the point-of-care. OssView Bone Fragility software analyzes HR-pQCT images to measure the bone microarchitecture.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.22 AUD
Average target price
0.48 AUD
Spread / Average Target
+118.18%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. CVB Stock
  4. News CurveBeam AI Limited
  5. CurveBeam AI Secures US FDA Clearance for CT Scanner; Shares Up 6%